BSE filing, NSE: AKSHARCHEM. Summary written from the filing by ALFA Finder's alert engine.
AksharChem (India) Ltd: key numbers
- Share price
- ₹383.80
- Market cap
- ₹308.3 Cr
- Revenue (annual)
- ₹372.4 Cr
- Net profit (annual)
- ₹-0.44 Cr
- P/E (TTM)
- 10.7×Sector 34.5×
- Promoter holding
- 62.70%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AksharChem (India) Ltd
All →AksharChem (India) Annual General Meeting
Aksharchem India seeks shareholder approval by postal ballot for its MD & CEO re-appointment and a whole-time director's remuneration revision. E-voting runs till 27 November 2026.
AksharChem (India) Management Change
AksharChem (India) Limited has re-appointed Mr. Munjal Mrugesh Jaykrishna as Managing Director & CEO and Mr. Sachin Munjal Jaykrishna as Whole Time Director.
AksharChem (India) Q2 FY27 Results: Turns Profitable, Net Profit ₹13.3 Cr
AksharChem (India) Ltd reported revenue from operations of ₹160.5 Cr (+79.7% YoY) and net profit of ₹13.3 Cr for Q2 FY27.
- Key figure
- Net profit ₹13.3 Cr
AksharChem (India) Other Announcement
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
AksharChem (India) Annual General Meeting
AksharChem India's 37th AGM approved audited financials, final dividend, and director re-appointments. No specific monetary figures disclosed in the proceedings.
AksharChem (India) Other Announcement
Aksharchem (India) Limited has provided the web-link and navigation path for shareholders to access the Annual Report and Notice of the 37th AGM.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.